The incontinence-associated dermatitis and its severity instrument: development and validation.
Kathleen Borchert, Donna Z Bliss, Kay Savik...
https://pubmed.ncbi.nlm.nih.gov/20736860Actively Recruiting
Phase Not Applicable
Age: 20Years +
FEMALE
ID06613503
Testing the Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections, Incontinence-associated Dermatitis and Caregiving Costs for Incontinence Patients
Led by China Medical University Hospital · Updated on 2024-09-26
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of the AI Supporter, an intelligent robot designed to manage excretion for incontinent patients. This study focuses on female patients who have been bedridden for more than three months and have urinary and/or fecal incontinence. The goal is to determine if using this AI-driven device can reduce the rates of urinary tract infections and incontinence-associated dermatitis while also exploring cost savings and caregiver burden reduction. The AI Supporter uses artificial intelligence-based vision recognition to detect urine and feces autonomously, then cleanses, dries, and changes the diaper without the need for caregiver intervention. Participants are randomly assigned to either the AI Supporter group or the traditional diaper care group. The intervention lasts for 14 days during which participants intermittently use the AI Supporter. Data such as excretion timing, frequency, and weight are recorded for analysis. During the study, participants will undergo routine urine analysis and assessments of incontinence-associated dermatitis, pressure sores, and skin pH. Researchers will also track caregiver hours and costs related to both diapers and the AI Supporter device. The primary outcomes measured are white blood cell count and bacterial count in urine 14 days after intervention. The study is conducted under single masking and uses statistical methods to evaluate outcomes with significance set at p < 0.05.
CONDITIONS
Brief Title
Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections
Who Can Participate
Age: 20Years +
FEMALE
Eligibility Criteria
You may qualify if you...
- Female participants aged over 20 years old
- Participants bedridden for at least 3 months
- Participants with urinary and/or fecal incontinence
- Participants able to wear the AI-supporter device during the study period
You will not qualify if you...
- Participants with severe skin conditions unrelated to incontinence
- Participants with current urinary tract infections or incontinence-associated dermatitis at enrollment
- Participants unable to provide informed consent or without a legal representative to do so
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Implementation
Duration - 14 days
Participants use the AI-supporter device which autonomously detects and cleanses affected areas to reduce urinary tract infections and incontinence-associated dermatitis.
Intermittent use over 14 days
Trial Site Locations
Total: 1 location
1
Rom A Master List, Extracted From This Organization'S Records.
Taichung, Taiwan
Actively Recruiting
Loading map...
Research Team
K
Kwo-Chen Lee, ph.D
J
Jing-ya Fu
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Etiologic factors in diaper dermatitis: the role of feces.
K W Buckingham, R W Berg
https://pubmed.ncbi.nlm.nih.gov/3513143Management of night-time urinary incontinence in residential settings for older people: an investigation into the effects of different pad changing regimes on skin health.
Mandy Fader, Sinead Clarke-O'Neill, Dawn Cook...
https://pubmed.ncbi.nlm.nih.gov/12709112Incontinence-associated dermatitis in elderly patients: prevalence and risk factors.
Mariana Ferreira, Luciana Abbade, Silvia Cristina Mangini Bocchi...
https://pubmed.ncbi.nlm.nih.gov/32696899Disposable Versus Reusable Absorbent Underpads for Prevention of Hospital-Acquired Incontinence-Associated Dermatitis and Pressure Injuries.
Kathleen Francis, Sau Man Pang, Brenda Cohen...
https://pubmed.ncbi.nlm.nih.gov/28549048Optimal management of incontinence-associated dermatitis in the elderly.
Mikel Gray
https://pubmed.ncbi.nlm.nih.gov/20131923pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion.
Jean-Pierre Hachem, Debra Crumrine, Joachim Fluhr...
https://pubmed.ncbi.nlm.nih.gov/12880427Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study.
Elisabeth Hahnel, Ulrike Blume-Peytavi, Carina Trojahn...
https://pubmed.ncbi.nlm.nih.gov/29132305Examining Prevalence and Risk Factors of Incontinence-Associated Dermatitis Using the International Pressure Ulcer Prevalence Survey.
Susan A Kayser, LeeAnn Phipps, Catherine A VanGilder...
https://pubmed.ncbi.nlm.nih.gov/31276451Aging enhances maceration-induced ultrastructural alteration of the epidermis and impairment of skin barrier function.
Takeo Minematsu, Yuko Yamamoto, Takashi Nagase...
https://pubmed.ncbi.nlm.nih.gov/21498052